AbCellera Biologics (STU:8QQ) Short Percentage of Float

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:8QQ AbCellera Biologics Inc STU:8QQ
63 GF Score
Price €4.66
GF Value €4.43
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is AbCellera Biologics Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

STU:8QQ vs AGIO, KOD, IMNM: Short Percentage of Float Comparison

For the Biotechnology subindustry, AbCellera Biologics's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AbCellera Biologics Short Percentage of Float vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AbCellera Biologics's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where AbCellera Biologics's Short Percentage of Float falls into.


STU:8QQ
63GF Score
AbCellera Biologics Inc STU:8QQ
Short Percentage of Float is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is AbCellera Biologics (STU:8QQ) Overvalued in 2026?

Based on GuruFocus' analysis, AbCellera Biologics stock appears to be overvalued. The current stock price of €4.66 is trading 5.2% above its estimated GF Value™ of €4.43. GuruFocus considers AbCellera Biologics to be Fairly Valued.

Key valuation signals for STU:8QQ:

  • Short Percentage of Float:
  • GF Value™: €4.43 vs. price of €4.66 (5.2% above fair value)
  • GF Score™: 63/100 with 4 warning signs

No single metric tells the full story. See the STU:8QQ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

AbCellera Biologics Business Description

Other Exchanges ABCL:USA8QQ:Germany
Address 150 W 4th Avenue, Vancouver, BC, CAN, V5Y 1G6
AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.
63GF Score

Get the complete analysis for STU:8QQ

Short Percentage of Float is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.66
Price
€4.43
GF Value